Type 2 Diabetes Trial, Recruiting NCT07416799 Sponsor: The University of Texas Medical Branch, Galveston Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07416799
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 55 and 80 years old
  • People who have been diagnosed with type 2 diabetes for at least 5 years
  • People who have been identified as having mild cognitive impairment (mild memory or thinking difficulties), confirmed by a specific memory test called the MoCA with a score between 18 and 25
  • People whose medications have remained the same for at least 3 months
  • People who are physically able to do moderate-intensity exercise, with clearance confirmed by a doctor
  • People who have a carer or support person available to help with technology use if needed

Who may not be able to join:

  • People who have been diagnosed with a movement disorder such as multiple sclerosis or Parkinson's disease
  • People who have been diagnosed with Alzheimer's disease
  • People who currently have severe depression, bipolar disorder, psychosis, schizophrenia, or alcohol dependence
  • People who have significant disease affecting the blood vessels in the brain
  • People who are currently taking certain medications that have notable effects on memory, thinking, or the nervous system — including some antipsychotics, certain antidepressants, anticonvulsants, sleeping tablets, anxiety medications, or long-term steroid treatments (confirm with trial site)
  • People whose vision or hearing difficulties would significantly affect their ability to complete thinking and memory tests
  • People with serious illness or major organ problems, including liver failure, kidney failure, or unstable heart disease
  • People with untreated vitamin B12 deficiency or an underactive thyroid that has not been treated and stable for at least 3 months
  • People with high blood pressure that is not well controlled (above 160/100 mmHg and not being treated)
  • People with severely reduced kidney function (stage 5 kidney disease, or currently on dialysis)
  • People who are currently taking part in another clinical trial
  • People who are currently imprisoned
  • People with any health condition that would make moderate-intensity exercise unsafe, such as severe aortic heart valve disease, poorly controlled high blood pressure, chest pain on exertion, or episodes of fainting
  • People who do not have a carer or support person available to help with technology use

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mandeep Sandhu, PhD, PT, University of Texas Medial Branch

Phone: (409)772-1011

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas Medical Branch, Galveston
Registry
ClinicalTrials.gov
Start date
14 April 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Technology-Assisted Home-Based Exercise Program; Acceptability of Technology-Assisted Home-Based Exercise Program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov